Definium Therapeutics (DFTX) Non Operating Investment Income (2025 - 2026)
Definium Therapeutics (DFTX) posted quarterly Non Operating Investment Income of -$262000.0 for Q1 2026, down 2720.0% year-over-year from $10000.0 in Q1 2025, and down 397.73% quarter-over-quarter from $88000.0 in Q4 2025.
Definium Therapeutics (DFTX) Non Operating Investment Income (2025 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has reported Non Operating Investment Income for 2 consecutive years, with -$262000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Investment Income fell 2720.0% year-over-year to -$262000.0; the TTM figure through Mar 2026 stood at $58000.0 (changed N/A YoY), while the FY2025 annual figure was $330000.0, changed N/A from the prior year.
- Non Operating Investment Income retreated to -$262000.0 in Q1 2026 per DFTX's latest filing, from $88000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $196000.0 in Q3 2025 and bottomed at -$262000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Definium Therapeutics | 4.72 Bn | 4.72 Bn | - | -406,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -406,000.00 |
| Jun 30, 2026 | -406,000.00 |
| Mar 31, 2026 | -262,000.00 |
| Mar 31, 2026 | -262,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |